- Home
- AEYE vs TIL Comparison
AEYE vs TIL Comparison
Compare AEYE & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AEYE | TIL |
|---|---|---|
| Founded | 2005 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.9M | 177.1M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | AEYE | TIL |
|---|---|---|
| Price | $12.30 | $12.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $22.00 | ★ $100.67 |
| AVG Volume (30 Days) | ★ 109.5K | 73.8K |
| Earning Date | 11-04-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $39,540,000.00 | N/A |
| Revenue This Year | $17.16 | N/A |
| Revenue Next Year | $14.79 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 18.57 | N/A |
| 52 Week Low | $8.91 | $10.80 |
| 52 Week High | $28.50 | $42.79 |
Technical Indicators
Market Signals| Indicator | AEYE | TIL |
|---|---|---|
| Relative Strength Index (RSI) | 44.56 | 39.66 |
| Support Level | $11.04 | $11.26 |
| Resistance Level | $12.92 | $13.50 |
| Average True Range (ATR) | 0.73 | 1.33 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 43.88 | 30.17 |
Price Performance
Historical ComparisonAbout AEYE AudioEye Inc.
AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. Trusted by the ADP, Tommy Hilfiger, A360 Media, Samsung, Landry's and others. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.